Evaluate MAbs RBD1106, R107 0,5mg of each FOC
When ordering online, write “FOC Offer” to the remarks field.
Terms: The special offer opportunity is only available to end users. Institutes and universities are not included in this promotion. The usual shipping and handling costs will still apply. The opportunity is a one-time evaluation possibility, feedback about the evaluation results is expected and you can get more details by contacting HyTest customer service at firstname.lastname@example.org.
RBD5305, RBD5308, RBD5313, RBD4319, RBD5324
R107, RBD1106: Hybridoma clones have been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with recombinant SARS-CoV-2 Spike RBD.
RBD5305, RBD5308, RBD5313, RBD5324: Recombinant full-sized chimeric MAbs, expressed in mammalian cells. Original wild type variable domains of rat MAb and human IgG1 constant domains are combined in these constructs.
RBD4319: Rat MAb produced in rat-mouse heterohybridoma cell line.
SARS-CoV-2 Spike RBD
IgG1 for R107, RBD1106, RBD5305, RBD5308, RBD5313, RBD4319, RBD5324
Immunoassays. Recommended pairs in sandwich immunoassay (capture – detection): here
Protein A chromatography
PBS, pH 7.4, 0.09 % sodium azide (NaN3)
+4 °C (+2 … +8 °C allowed)
This product is sold for research or further manufacturing use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
(Catalogue number and MAb: 3CV2-)